# Avantor, Inc. (AVTR) stock: price and valuation

URL: https://funkfolio.com/stock/AVTR

> Avantor, Inc. (AVTR) trades at $15.21, is worth $10.3B, is priced at 30.4× earnings and scores 34/100. Valuation, financials and signals.

---

## Avantor, Inc. (AVTR)

Avantor, Inc. (AVTR) is a healthcare company (medical instruments & supplies) based in the United States. The share price is $15.21, down 0.75% on the day, which values the company at $10.3B. Price as of 17 Nov 2026, 19:21 UTC, from Yahoo Finance.

### Key facts

- **Share price:** $15.21 −0.75% today
- **Market value:** $10.3B
- **P/E ratio:** 30.4× last 12 months
- **Forward P/E:** 17.1×
- **Funk Score:** 34/100
- **Against its own history:** Well below its usual price usual price $22.26
- **200-week average:** $17.81 15% below
- **Sector:** Healthcare

Figures as of 17 Nov 2026, 19:21 UTC. Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

### Avantor, Inc. in more detail

AVTR trades at 30.4× its last twelve months' earnings, 17.1× next year's expected earnings, 1.6× sales. Measured against its own history, the price is 32% below what its usual multiples would imply ($22.26) — well below its usual price. It sits 15% below its 200-week average of $17.81.

Over the last five fiscal years Avantor, Inc. has compounded revenue 0.5% a year, free cash flow -10.6% a year. Its Funk Score is 34 out of 100 (financial strength 2.3, profitability 3.0, growth 1.4, value 7.0, each out of 10).

Worth checking: Gross margin is shrinking; Revenue is shrinking.

9 of the superinvestors tracked here hold AVTR, including Arnaud Ajdler (19.1% of the portfolio), Edgar Wachenheim (4.6% of the portfolio), Mason Hawkins (2.4% of the portfolio).

### Superinvestors holding AVTR

9 of the investors tracked here report a position in their latest 13F filing.

- [Arnaud Ajdler Engine Capital](https://funkfolio.com/gurus/arnaud-ajdler) 19.1% of portfolio · $196.6M · added · Q2 2026
- [Edgar Wachenheim Greenhaven Associates](https://funkfolio.com/gurus/edgar-wachenheim) 4.61% of portfolio · $366.6M · trimmed · Q3 2026
- [Mason Hawkins Southeastern Asset Management (Longleaf)](https://funkfolio.com/gurus/mason-hawkins) 2.44% of portfolio · $46.8M · added · Q2 2026
- [David Greenspan Slate Path Capital](https://funkfolio.com/gurus/david-greenspan) 1.65% of portfolio · $103.5M · new · Q3 2026
- [Steven Romick First Pacific Advisors (FPA)](https://funkfolio.com/gurus/steven-romick) 1.12% of portfolio · $94.1M · trimmed · Q3 2026
- [Dodge & Cox team Dodge & Cox](https://funkfolio.com/gurus/dodge-and-cox) 0.96% of portfolio · $1.8B · trimmed · Q3 2026
- [Stephen Yacktman Yacktman Asset Management](https://funkfolio.com/gurus/stephen-yacktman) 0.86% of portfolio · $71.8M · Q3 2026
- [Chuck Royce (founder) Royce & Associates](https://funkfolio.com/gurus/chuck-royce) 0.46% of portfolio · $50.4M · trimmed · Q3 2026
- [Diamond Hill team Diamond Hill Capital Management](https://funkfolio.com/gurus/diamond-hill) 0.15% of portfolio · $14.2M · trimmed · Q3 2026

### Health Care companies of similar size

- [Universal Health Services UHS](https://funkfolio.com/stock/UHS)
- [Repligen RGEN](https://funkfolio.com/stock/RGEN)
- [Bio-Techne TECH](https://funkfolio.com/stock/TECH)
- [BioMarin Pharmaceutical BMRN](https://funkfolio.com/stock/BMRN)
- [Ensign Group ENSG](https://funkfolio.com/stock/ENSG)
- [Vaxcyte PCVX](https://funkfolio.com/stock/PCVX)
- [Bio-Rad Laboratories BIO](https://funkfolio.com/stock/BIO)
- [Molina Healthcare MOH](https://funkfolio.com/stock/MOH)
- [Spyre Therapeutics SYRE](https://funkfolio.com/stock/SYRE)
- [Qiagen QGEN](https://funkfolio.com/stock/QGEN)
- [Insulet PODD](https://funkfolio.com/stock/PODD)
- [Bruker BRKR](https://funkfolio.com/stock/BRKR)

Side by side: [AVTR vs ENSG (Avantor, Inc. vs Ensign Group)](https://funkfolio.com/compare/avtr-vs-ensg) [AVTR vs PCVX (Avantor, Inc. vs Vaxcyte)](https://funkfolio.com/compare/avtr-vs-pcvx) [AVTR vs BIO (Avantor, Inc. vs Bio-Rad Laboratories)](https://funkfolio.com/compare/avtr-vs-bio) [AVTR vs MOH (Avantor, Inc. vs Molina Healthcare)](https://funkfolio.com/compare/avtr-vs-moh) [AVTR vs BMRN (Avantor, Inc. vs BioMarin Pharmaceutical)](https://funkfolio.com/compare/avtr-vs-bmrn)

[All health care companies by market value](https://funkfolio.com/companies/sector/health-care) [Largest companies in the United States](https://funkfolio.com/companies/country/united-states) [All stocks A–Z](https://funkfolio.com/stocks)

### Avantor, Inc. (AVTR): questions and answers

**What is AVTR's P/E ratio?**

Avantor, Inc. trades at 30.4× its last twelve months' earnings and 17.1× next year's expected earnings. At its fiscal year-ends over the past 5 years the P/E ranged from 20.3× to 312.8×, with a median of 48.6×.

**What is Avantor, Inc.'s market cap?**

Avantor, Inc. is valued at $10.3B at a share price of $15.21.

**Is AVTR overvalued or undervalued?**

Against its own history, AVTR is well below its usual price: the price is 32% below the $22.26 implied by the median multiples it has traded at (price / earnings, price / sales, price / book, price / free cash flow). That compares the stock with its past; it does not say whether the business now deserves a higher or lower multiple.

**Is AVTR above its 200-week moving average?**

No. AVTR is 14.6% below its 200-week average of $17.81. Long-term investors watch that line because strong companies rarely trade below it for long.

**How fast is Avantor, Inc. growing?**

Over the last five fiscal years Avantor, Inc.'s revenue grew 0.5% a year.

**Does AVTR pay a dividend?**

Avantor, Inc. does not currently pay a regular dividend.

### Learn to read these numbers

[All stocks guides →](https://funkfolio.com/learn/stocks)

- [Altman Z-score: formula, zones and where it fails](https://funkfolio.com/learn/stocks/altman-z-score)

  The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- [Analyst price targets and ratings: what they mean](https://funkfolio.com/learn/stocks/analyst-price-targets)

  An analyst price target is a research analyst's estimate of where a share price will be at a set horizon, such as twelve months; a rating such as buy or hold is that analyst's recommendation. A consensus is an average or median of the targets a data provider has collected. Studies have found targets on average well above later prices.
- [Free cash flow and FCF yield explained](https://funkfolio.com/learn/stocks/free-cash-flow)

  Free cash flow is the cash a business generates from operations minus what it spends on equipment, buildings and other long-lived assets. Free-cash-flow yield divides that cash by the company's market value: $5 billion of free cash flow on a $100 billion company is a 5% yield. It is cash available to owners and lenders, not profit.

### Cite this page

Funkfolio, “Avantor, Inc. (AVTR) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/AVTR

Underlying data: Yahoo Finance; company filings with the SEC.
